SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000898430-00-002201
Filing Date
2000-08-01
Accepted
2000-08-01 00:00:00
Documents
11
Period of Report
2000-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 0001.txt 10-Q 76754
2 RESTATED CERTIFICATE OF INCORPORATION 0002.txt EX-3.3 2822
3 CERTIFICATE OF DESIGNATIONS 0003.txt EX-3.4 2415
4 AMENDMENTS TO SHAREHOLDERS' AGREEMENT - KIRIN AMGEN 0004.txt EX-10.4 125773
5 PRODUCT LICENSE AGREEMENT - AMGEN AND ORTHO 0005.txt EX-10.5 154842
6 PRODUCT LICENSE AGREEMENT - KIRIN AMGEN AND ORTHO 0006.txt EX-10.6 128768
7 AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN 0007.txt EX-10.7 25573
8 FIRST AMENDMENT TO CHANGE OF CONTROL SEVERANCE PLAN 0008.txt EX-10.19 1975
9 AGREEMENT BETWEEN AMGEN AND MR. GORDON M. BINDER 0009.txt EX-10.43 52830
10 FINANCIAL DATA SCHEDULE 0010.txt EX-27 2447
11 FACTORS THAT MAY AFFECT AMGEN 0011.txt EX-99 12840
  Complete submission text file 0000898430-00-002201.txt   590112
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12477 | Film No.: 683776
SIC: 2836 Biological Products, (No Diagnostic Substances)